Skip to main content

Municipality Finance issues a NOK 1 billion tap under its MTN programme

Municipality Finance PlcStock exchange release 29 January 2025 at 10:00 am (EET) Municipality Finance issues a NOK 1 billion tap under its MTN programme On 30 January 2025 Municipality Finance Plc issues a new tranche in an amount of NOK 1 billion to an existing series of notes issued on 15 January 2025. With the new tranche, the aggregate nominal amount of the notes is NOK 4 billion. The maturity date of the notes is 15 January 2030. The notes bear interest at a floating rate equal to 3-month Nibor plus 25 bps per annum. The new tranche is issued under MuniFin’s EUR 50 billion programme for the issuance of debt instruments. The offering circular, the supplemental offering circular and final terms of the notes are available in English on the company’s website at https://www.kuntarahoitus.fi/en/for-investors. MuniFin has applied...

Continue reading

Offentliggørelse af prospekt samt formue og investorer for afdelingen I&T Obligationer KL i Investeringsforeningen Wealth Invest

Hermed offentliggøres prospekt samt formue og antal investorer for afdelingen I&T Obligationer KL, som optages til handel på Nasdaq Copenhagen A/S med første handelsdag 31. januar 2025.Afdeling Formue DKK Antal navnenoterede investorerI&T Obligationer   17.765.000 169Hvis der måtte være spørgsmål i relation til ovenstående, kan der rettes henvendelse til direktør i Wealth Fund Partners A/S, Lise Bøgelund Jensen på telefon 3328 2828.  Med venlig hilsen Investeringsforeningen Wealth InvestAttachment2025 01 31 WI I&T_børsprospekt_final

Continue reading

ONWARD Medical’s ARC-EX System Now Available on US Veterans Affairs Online Procurement Platforms

ONWARD ARC-EX System for spinal cord injury is now available for purchase through VA Federal Supply Schedule and GSA Advantage platforms Partnership with Lovell Government Services is providing commercial benefit, facilitating purchase through validated US government online purchasing platforms EINDHOVEN, the Netherlands, Jan. 29, 2025 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities today announces it has secured the required approvals to enable Veterans Affairs (VA) and other government agencies to immediately purchase the ARC-EX System through federal procurement systems. This milestone is the first major benefit resulting...

Continue reading

Webuy Global Ltd. Receives Nasdaq Notification Regarding Non-Compliance with Minimum Bid Price Rule

Singapore, Jan. 28, 2025 (GLOBE NEWSWIRE) — Webuy Global Ltd. (Nasdaq: WBUY) (the “Company”), today announced that it received a letter on January 22, 2025, from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has not regained compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”), which requires listed securities to maintain a minimum bid price of $1.00 per share. As a result, the Nasdaq staff has issued a Staff Delisting Determination, and the trading of the Company’s Class A ordinary shares will be suspended at the opening of business on January 29, 2025. The Minimum Bid Price Rule requires listed securities to achieve a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days within the compliance period. Despite...

Continue reading

89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants

SAN FRANCISCO, Jan. 28, 2025 (GLOBE NEWSWIRE) — 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced the pricing of its previously announced upsized underwritten public offering of 21,671,428 shares of its common stock at a public offering price per share of $8.75 and, in lieu of common stock to a certain investor, pre-funded warrants to purchase up to 6,900,000 shares of its common stock at a public offering price of $8.749. The pre-funded warrants have an exercise price of $0.001 per share and are exercisable immediately. In addition, 89bio has granted the underwriters of the offering an option for a period of 30 days to purchase up to an additional 4,285,714...

Continue reading

Akero Therapeutics Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants

SOUTH SAN FRANCISCO, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked by high unmet medical need, announced today the pricing of an upsized underwritten public offering of 5,333,420 shares of its common stock at a public offering price of $48.00 per share and, in lieu of common stock to certain investors that so choose, pre-funded warrants to purchase 1,958,247 shares of common stock at a public offering price of $47.9999 per pre-funded warrant, which represents the per share public offering price for the common stock less the $0.0001 per share exercise price for each pre-funded warrant. All of the shares and pre-funded warrants in the offering are being offered by Akero. In addition,...

Continue reading

Wearable Devices Ltd. Announces Pricing of $2.5 Million Public Offering

Yokneam Illit, Israel, Jan. 28, 2025 (GLOBE NEWSWIRE) — Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), an award-winning pioneer in artificial intelligence (“AI”)-based wearable gesture control technology, today announced the pricing of its “reasonable best efforts” public offering with a single institutional investor for the purchase and sale of up 2,500,000 ordinary shares (or pre-funded warrants in lieu thereof) and warrants to purchase up to 2,500,000 ordinary shares, at a combined offering price of $1.00 per share and accompanying warrant (the “Offering”). The Company expects to receive aggregate gross proceeds of approximately $2.5 million, before deducting placement agent fees and other offering expenses and assuming no exercise of the warrants. The warrants will have an exercise...

Continue reading

McEwen Mining: 2024 Production Within Guidance; 2025 Guidance: Stable Production and Cost/Oz

TORONTO, Jan. 28, 2025 (GLOBE NEWSWIRE) — McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is pleased to report full-year 2024 consolidated production of 135,900 gold equivalent ounces (“GEOs”)(1), within our guidance range for the year (press release dated Feb 12, 2024). During 2024, Gold Bar and San Jose produced 44,600 and 60,100 GEOs, respectively, slightly exceeding the top end of our guidance ranges for those operations. At the Fox Complex, we produced 30,150 GEOs, which was below annual guidance due to a stope failure in early 2024 impacting production.Table 1: Consolidated 2024 Production and 2025 Guidance Summary         Full Year2024(3)(4) 2024Guidance(4) 2025 GuidanceConsolidated Production    GEOs(1) 135,900 130,000 – 145,000 120,000 – 140,000Cash Costs/GEO     $1,550 – $1,750AISC/GEO     $1,800...

Continue reading

Vortex Announces Closing of Private Placement of C$400,000 of Unsecured Convertible Debentures

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Jan. 28, 2025 (GLOBE NEWSWIRE) — Vortex Energy Corp. (CSE: VRTX | OTC: VTECF | FRA: AA3) (“Vortex” or the “Company“) is pleased to announce that it has closed its previously announced non-brokered private placement of unsecured convertible debentures of the Company (the “Convertible Debentures”) for aggregate gross proceeds to the Company of C$400,000 (the “Offering”). The Convertible Debentures are denominated in principal amounts of C$1,000 and will mature on January 24, 2026 (the “Maturity Date”). The Convertible Debentures will bear interest at a rate of 10% per annum from the issue date, calculated quarterly in arrears and payable on the Maturity Date. The Company may prepay the...

Continue reading

Oak Valley Community Bank to Open New Branch in Lodi

OAKDALE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) — Oak Valley Community Bank, a wholly owned subsidiary of Oak Valley Bancorp (NASDAQ: OVLY) recently announced it has received regulatory approval to establish its 19th full-service branch. The new office will be located at 31 South School Street in downtown Lodi and is scheduled to open mid-2025. Established in 1991, Oak Valley Community Bank opened its first branch in San Joaquin County in 2005. The Lodi Branch will be the bank’s sixth location in the county and offer a full line of personal and commercial banking services, a traditional walk-up ATM, and night deposit service. The branch will also include offices for commercial lending and administrative personnel. “We are pleased to expand our branch network into Lodi. This adds another convenient location to our footprint,” stated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.